Neutra

Neutra Tax Expense

The Income Tax Expense of Neutra (NTRR) as of Oct 24, 2026 is 639.00 USD. In the previous year, Income Tax Expense was 639.00 USD — a change of 0.00% (lower).

Tax Expense

639.00USD

YoY

0.00%

Last updated:

Income Tax Expense of Neutra is 2025 639.00 USD. Income Tax Expense of Neutra was 2024 639.00 USD. It decreases by 0.00% lower compared to the previous year.

The Neutra Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2018
-163,684.00 USD
Jan 1, 2019
720,750.00 USD
Jan 1, 2020
340,701.00 USD
Jan 1, 2021
121,648.00 USD
Jan 1, 2022
127.45 B USD
Jan 1, 2023
3,523.00 USD
Jan 1, 2024
639.00 USD
Jan 1, 2025
639.00 USD
The Neutra Tax Expense history
YEARTax ExpenseYoY
639.00USD0.00%
639.00USD-81.86%
3,523.00USD-100.00%
127.45 BUSD+104.77 M%
121,648.00USD-64.29%
340,701.00USD-52.73%
720,750.00USD-540.33%
-163,684.00USD-55.85%
-370,726.00USD-74.21%
-1.44 MUSD-379.11%
515,083.00USD-153.33%
-965,903.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neutra Stock analysis

What does Neutra do? Neutra Corp. generates revenue by marketing and selling nutraceutical products derived from all natural and organic origins, primarily focusing on the medical cannabis market. The company sells hemp-derived products, including those containing delta-8-THC and other cannabinoids, under its own brand. It entrusts manufacturing to a nutraceutical contractor for private labeling, targeting consumers interested in healthy living solutions. Subsidiaries such as Diamond Anvil Designs, LLC, Deity Corporation, and Vivis Corporation support its operations. The firm's primary customers are consumers seeking natural health products, particularly within the growing nutraceutical sector. Products are sold under the Neutra Corp. brand, emphasizing all-natural and organic origins. The company plans to research new technologies for the nutraceutical space, aiming to expand its product offerings in the medical cannabis sub-market. Neutra Corp. operates in the nutraceutical space by leveraging private-label manufacturing, allowing it to focus on research and development of new technologies. Its product line centers around hemp-derived items, including delta-8-THC products, which are sold directly to end consumers. The company's strategy involves expanding its presence in the medical cannabis market through branded, organic, and natural health solutions. Neutra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neutra stock

Income Tax Expense of Neutra is 639.00 USD in 2025.

Income Tax Expense of Neutra changed from 639.00 USD to 639.00 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Neutra since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Neutra historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Neutra

All Key Metrics — Neutra